Overview
Investment firm focused on women's health and female-led life sciences.
Founded
2019
Deals ยท 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Mercy BioAnalytics | Sep 2025Participated | $59 MSeries B | |
Novocuff | Jul 2024Participated | $26 MSeries A | |
Axena Health | Jun 2024Participated | $9 MSeries A | |
May Health | May 2024Participated | $25 MSeries B | |
Midi Health | Apr 2024Participated | $60 MSeries B | |
Avation Medical | Feb 2024Participated | $22 MSeries C | |
AOA | Sep 2022Led | $7 MOther Equity | |
Raydiant Oximetry | Nov 2021Led | $5 MSeries A | |
Antiva Biosciences | Nov 2021Participated | $31 MSeries D | |
Mae | Sep 2021Participated | $1 MSeed | |
Genome Medical | Aug 2021Participated | $60 MSeries C | |
AOA | Jun 2021Participated | $3 MSeed | |
Mercy BioAnalytics | Sep 2025Participated | $59 MSeries B | |
Novocuff | Jul 2024Participated | $26 MSeries A | |
Axena Health | Jun 2024Participated | $9 MSeries A | |
May Health | May 2024Participated | $25 MSeries B | |
Midi Health | Apr 2024Participated | $60 MSeries B | |
Avation Medical | Feb 2024Participated | $22 MSeries C | |
AOA | Sep 2022Led | $7 MOther Equity | |
Raydiant Oximetry | Nov 2021Led | $5 MSeries A | |
Antiva Biosciences | Nov 2021Participated | $31 MSeries D | |
Mae | Sep 2021Participated | $1 MSeed | |
Genome Medical | Aug 2021Participated | $60 MSeries C | |
AOA | Jun 2021Participated | $3 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 2 |
| Series A | 1 | 2 |
| Series B | 0 | 4 |
| Series C+ | 0 | 4 |
| Other Equity | 1 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Dec '19 | 1 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 2 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 2 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 1 |
| Jun '24 | 1 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 14 |
| Consumer & Lifestyle | 2 |
| Networks, Cloud & Communication | 1 |
| Education & Workforce | 1 |
| Hardware & Robotics | 1 |
| Enterprise Software | 1 |
| Manufacturing | 1 |
| Space & Frontier Tech | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 3 |
| $10M-$25M | 3 |
| $25M-$50M | 3 |
| $50M-$100M | 3 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 13 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| AXA IM Alts | 3 |
| Canaan Partners | 3 |
| Google Ventures | 3 |
| SteelSky Ventures | 3 |
| AlleyCorp | 2 |
| Casdin Capital | 2 |
| Dreamers VC | 2 |
| Echo Health Ventures | 2 |
| Flywheel Ventures | 2 |
| HealthInvest Equity Partners | 2 |
| Illumina Ventures | 2 |
| Kaiser Permanente Ventures | 2 |
| KOFA Healthcare | 2 |
| LRVHealth | 2 |
| Perceptive Advisors | 2 |
| Revelation Partners | 2 |
| RH Capital | 2 |
| Rhia Ventures | 2 |
| SideCar Angels | 2 |
| 1843 Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 13% |
| Participating | 13 | 87% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 50% |
| Co-led | 1 | 50% |
Team
Co-founder & Managing Partner